Hormone Fluctuations Have Complicated Hypertension Screening

New findings show that intermittent hormone spikes in people with adrenal issues may cause one-time tests to miss diagnoses.

Updated on Sept. 19, 2026 in Diabetes

Bold vector editorial illustration showing abstract interlocking spheres and fluid waves representing hormonal fluctuations in clinical diagnostics.
Researchers report that irregular aldosterone fluctuations often lead to missed diagnoses of primary aldosteronism during standard hypertension screenings. AI Illustration. Upload story photo >

Live Poll

Do you trust that standard medical screenings are sufficient to detect all causes of hypertension?

Researchers have discovered that aldosterone levels fluctuate in hormonal bursts throughout the day rather than remaining constant, potentially leading to missed diagnoses of primary aldosteronism. This challenge is significant given that millions globally struggle with managing hypertension.

Why it matters

Current diagnostic standards rely on one-time measurements that may fail to detect primary aldosteronism, a condition driving high blood pressure and low potassium. Improving diagnostic accuracy could change how hypertension is managed for the large population currently struggling to control it.

In a study of 60 adults with primary aldosteronism, researchers used a wearable device to track hormone levels every 20 minutes to identify cyclical patterns. Findings indicate that these levels fluctuate, meaning a single, static measurement may not accurately reflect a person's risk.

The players

Researchers

A collaborative team based in the UK, Norway, Stockholm, and Athens investigating adrenal hormonal activity.

The details

Primary aldosteronism occurs when the adrenal glands overproduce aldosterone, a hormone responsible for managing the body's salt and water balance. In individuals with issues in one adrenal gland, this production happens in irregular bursts rather than a steady stream. Current clinical practice relies on a single aldosterone-to-renin ratio test, which may fail to capture these active hormonal phases and lead to misleading results.

Timeline

  1. September 19, 2026: Findings were published regarding hormone fluctuations.

Health Landscape

These findings highlight a significant limitation in the current aldosterone-to-renin ratio standard of care for hypertension. Moving beyond one-time blood draws toward dynamic hormonal mapping represents a necessary shift in how clinicians identify underlying adrenal causes of high blood pressure.

If you are managing hypertension that remains difficult to control despite standard treatment, it may be worth discussing the limitations of hormone screening with your doctor. Understanding that adrenal activity can fluctuate may help you and your physician interpret existing diagnostic tests more clearly.

The takeaway

The discovery that aldosterone fluctuates in bursts explains why one-time screening can be unreliable for identifying adrenal-related blood pressure issues. Consider talking to your doctor about your blood pressure trends and whether additional specialized testing is appropriate for your specific health history.

Further reading

Learn more about the latest research and clinical guidelines in our Diabetes section.

Source note: This article includes information reported by Deccan Herald.

Live Poll

Do you trust that standard medical screenings are sufficient to detect all causes of hypertension?